Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Chemring Falls as Weaker Outlook Seen Cutting Potential Offer

Aug. 28 (Bloomberg) -- Chemring Plc, which received a preliminary approach from Carlyle Group LP, dropped in London trading as investors saw a cut to this year’s profit target reducing any offer for the maker of missile-avoidance systems.

The company fell as much as 13 percent to 322.3 pence, its lowest level since announcing Carlyle’s interest on Aug. 17. Problems with a cost-management system and delays to the debut of an explosives clearing device will lower earnings by 15 million pounds ($24 million), Chemring said in a statement.

“Carlyle would have been unaware of the problems in their initial approach,” Credit Suisse analyst Oliver Sleath said in a note. “We think this would be more likely to result in a lower price for the bid, than affecting the probability of the takeover going ahead.”

Chemring’s order book shrank 9 percent at the end of July from a year earlier because of the slow approval processes for export licenses in many European countries and the early timing of Ramadan and its impact on Middle East bookings. Overall, quarterly sales advanced 4 percent.

The Fareham, England-based company traded at 325.3 pence as of 9:09 a.m. local time.

To contact the reporter on this story: Robert Wall in London at rwall6@bloomberg.net

To contact the editor responsible for this story: Benedikt Kammel at bkammel@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.